[
  {
    "ts": null,
    "headline": "Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback",
    "summary": "AZN and BAYRY announce Q3 results. ABBV's studies on schizophrenia candidate, emraclidine, fail to meet goal.",
    "url": "https://finnhub.io/api/news?id=667ec7580222c19495264d3bde0e98d22f280a30d8f966a47dbd9ea1a54972e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731700800,
      "headline": "Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback",
      "id": 131381097,
      "image": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AZN and BAYRY announce Q3 results. ABBV's studies on schizophrenia candidate, emraclidine, fail to meet goal.",
      "url": "https://finnhub.io/api/news?id=667ec7580222c19495264d3bde0e98d22f280a30d8f966a47dbd9ea1a54972e3"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock underperforms Friday when compared to competitors",
    "summary": "AbbVie Inc. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=85c4fc64d5036f4cb9b3190f7a51423bab3593b7407be17f876a7092e83010ca",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731688500,
      "headline": "AbbVie Inc. stock underperforms Friday when compared to competitors",
      "id": 131414138,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=85c4fc64d5036f4cb9b3190f7a51423bab3593b7407be17f876a7092e83010ca"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?",
    "summary": "Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.",
    "url": "https://finnhub.io/api/news?id=214aa2d6c712acf4e4af98516e743b57835e67fe67bf83fe600fd915c4b350ff",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731683280,
      "headline": "AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?",
      "id": 131389005,
      "image": "https://media.zenfs.com/en/zacks.com/6d12ae6d407957348a46f55b412dfc98",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Investors who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return to robust growth next year.",
      "url": "https://finnhub.io/api/news?id=214aa2d6c712acf4e4af98516e743b57835e67fe67bf83fe600fd915c4b350ff"
    }
  },
  {
    "ts": null,
    "headline": "Tesla, Crypto, And The Trump Trade",
    "summary": "Shopify and AbbVie among the main stocks moving on catalysts this past week. Tesla, crypto and the Trump trade.",
    "url": "https://finnhub.io/api/news?id=4655547a7bbed5697479a3db62fe5198a79c5fb4f3dc6699c6b06d1f426252aa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731676500,
      "headline": "Tesla, Crypto, And The Trump Trade",
      "id": 131375398,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345558464/image_1345558464.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Shopify and AbbVie among the main stocks moving on catalysts this past week. Tesla, crypto and the Trump trade.",
      "url": "https://finnhub.io/api/news?id=4655547a7bbed5697479a3db62fe5198a79c5fb4f3dc6699c6b06d1f426252aa"
    }
  },
  {
    "ts": null,
    "headline": "Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock",
    "summary": "The drugmaker has convincingly laid to rest the biggest threat to its top line.",
    "url": "https://finnhub.io/api/news?id=672c087de9d725fceb31db74891cab474c6c94f316b261400dff35ae73ca4159",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731667800,
      "headline": "Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its Stock",
      "id": 131369260,
      "image": "https://g.foolcdn.com/editorial/images/797564/scientists-lab-testing-blood-draw2.jpg",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The drugmaker has convincingly laid to rest the biggest threat to its top line.",
      "url": "https://finnhub.io/api/news?id=672c087de9d725fceb31db74891cab474c6c94f316b261400dff35ae73ca4159"
    }
  }
]